Fetal valproate syndrome

Fetal valproate syndrome (FVS), is an anticonvulsant drug-related embryofetopathy that can occur when a fetus is exposed to valproic acid (VPA), characterized by distinct facial dysmorphism, congenital anomalies and developmental delay (especially in language and communication).

Also known as: fetal valproate syndrome, fetal valproic acid syndrome, FVS, susceptibility to valproate embryopathy, valproate embryopathy, susceptibility to, valproic acid embryopathy

4 clinical trials for this condition and its sub-types.